Stock Events

Stock Events

Grace Therapeutics (GRCE) Q4 2025 Earnings

13NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.36

-0.2

-0.05

0.11

Details

Expected EPS

-0.2512

Actual EPS

-0.06

Surprise EPS

0.19

Surprise Percent

+76.11%

Description

Grace Therapeutics (GRCE) has reported earnings of -0.06 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.